James Claffey

1.1k total citations
37 papers, 953 citations indexed

About

James Claffey is a scholar working on Organic Chemistry, Oncology and Inorganic Chemistry. According to data from OpenAlex, James Claffey has authored 37 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Organic Chemistry, 23 papers in Oncology and 7 papers in Inorganic Chemistry. Recurrent topics in James Claffey's work include Organometallic Complex Synthesis and Catalysis (30 papers), Synthetic Organic Chemistry Methods (23 papers) and Metal complexes synthesis and properties (20 papers). James Claffey is often cited by papers focused on Organometallic Complex Synthesis and Catalysis (30 papers), Synthetic Organic Chemistry Methods (23 papers) and Metal complexes synthesis and properties (20 papers). James Claffey collaborates with scholars based in Ireland, Germany and Austria. James Claffey's co-authors include Matthias Tacke, Megan Hogan, Helge Müller‐Bunz, Clara Pampillón, Judith E. Tintinalli, Brendan Gleeson, Katja Strohfeldt, A. Deally, Siddappa A. Patil and Francesca Paradisi and has published in prestigious journals such as Inorganic Chemistry, European Journal of Medicinal Chemistry and Organometallics.

In The Last Decade

James Claffey

37 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Claffey Ireland 20 664 417 160 102 90 37 953
Surajit Chattopadhyay India 23 690 1.0× 509 1.2× 300 1.9× 61 0.6× 243 2.7× 66 1.1k
R. W. Matthews United Kingdom 13 240 0.4× 151 0.4× 201 1.3× 6 0.1× 145 1.6× 27 532
Dennis L. Nosco United States 12 105 0.2× 131 0.3× 93 0.6× 5 0.0× 70 0.8× 27 446
R. Venkataramanan India 13 338 0.5× 93 0.2× 25 0.2× 10 0.1× 32 0.4× 40 617
Yvon Coulais France 13 133 0.2× 141 0.3× 58 0.4× 4 0.0× 72 0.8× 50 559
David G. Parsons United States 9 83 0.1× 49 0.1× 24 0.1× 249 2.4× 22 0.2× 27 626
Noriyoshi Yamamoto Japan 12 651 1.0× 11 0.0× 297 1.9× 197 1.9× 54 0.6× 22 1.0k
Stephen Wolstenhulme United Kingdom 12 393 0.6× 29 0.1× 172 1.1× 9 0.1× 6 0.1× 30 817
Hidetoshi Inoue Japan 16 43 0.1× 103 0.2× 64 0.4× 5 0.0× 131 1.5× 80 597
Clark Smith United States 16 320 0.5× 14 0.0× 78 0.5× 49 0.5× 15 0.2× 46 553

Countries citing papers authored by James Claffey

Since Specialization
Citations

This map shows the geographic impact of James Claffey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Claffey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Claffey more than expected).

Fields of papers citing papers by James Claffey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Claffey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Claffey. The network helps show where James Claffey may publish in the future.

Co-authorship network of co-authors of James Claffey

This figure shows the co-authorship network connecting the top 25 collaborators of James Claffey. A scholar is included among the top collaborators of James Claffey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Claffey. James Claffey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Claffey, James, Megan Hogan, Patrick Jesse, et al.. (2011). The role of the intrinsic FAS pathway in Titanocene Y apoptosis: The mechanism of overcoming multiple drug resistance in malignant leukemia cells. Toxicology in Vitro. 26(1). 119–124. 19 indexed citations
2.
Fichtner, Iduna, Diana Behrens, James Claffey, et al.. (2011). The Antiangiogenic and Antitumoral Activity of Titanocene Y* In Vivo. Letters in Drug Design & Discovery. 8(4). 302–307. 15 indexed citations
3.
Dowling, Catherine, James Claffey, Clara Pampillón, et al.. (2010). Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage‐induced apoptosis. The Prostate. 71(2). 111–124. 14 indexed citations
4.
Deally, A., James Claffey, Brendan Gleeson, et al.. (2010). Synthesis and preliminary cytotoxicity studies of achiral pyrrolyl-substituted titanocenes. Polyhedron. 29(12). 2445–2453. 3 indexed citations
5.
Olszewski, Ulrike, James Claffey, Megan Hogan, et al.. (2010). Anticancer activity and mode of action of titanocene C. Investigational New Drugs. 29(4). 607–614. 26 indexed citations
6.
Gleeson, Brendan, James Claffey, A. Deally, et al.. (2010). Novel benzyl-substituted molybdocene anticancer drugs. Inorganica Chimica Acta. 363(8). 1831–1836. 21 indexed citations
7.
Erxleben, Andrea, James Claffey, & Matthias Tacke. (2009). Binding and hydrolysis studies of antitumoural titanocene dichloride and Titanocene Y with phosphate diesters. Journal of Inorganic Biochemistry. 104(4). 390–396. 23 indexed citations
8.
Claffey, James, A. Deally, Brendan Gleeson, et al.. (2009). Pseudo-halide derivatives of titanocene Y: synthesis and cytotoxicity studies. Metallomics. 1(6). 511–511. 12 indexed citations
9.
Claffey, James, Megan Hogan, Helge Müller‐Bunz, Clara Pampillón, & Matthias Tacke. (2008). Oxali‐Titanocene Y: A Potent Anticancer Drug. ChemMedChem. 3(5). 729–731. 45 indexed citations
10.
Tacke, Matthias, Megan Hogan, James Claffey, & Clara Pampillón. (2008). Synthesis and Cytotoxicity Studies of New Morpholino-Functionalised and N-Heteroaryl-Substituted Titanocene Anticancer Drugs. Medicinal Chemistry. 4(2). 91–99. 11 indexed citations
11.
12.
Gleeson, Brendan, James Claffey, Megan Hogan, et al.. (2008). Novel organotin antibacterial and anticancer drugs. Polyhedron. 27(18). 3619–3624. 63 indexed citations
13.
Claffey, James, Megan Hogan, Helge Mueller‐Bunz, Clara Pampillón, & Matthias Tacke. (2008). ChemInform Abstract: Oxali‐Titanocene Y: A Potent Anticancer Drug. ChemInform. 39(35). 4 indexed citations
14.
Weber, Holger, James Claffey, Megan Hogan, Clara Pampillón, & Matthias Tacke. (2007). Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay. Toxicology in Vitro. 22(2). 531–534. 25 indexed citations
15.
Pampillón, Clara, James Claffey, Megan Hogan, & Matthias Tacke. (2007). Novel achiral titanocene anti-cancer drugs synthesised from bis-N,N-dimethylamino fulvene and lithiated heterocyclic compounds. BioMetals. 21(2). 197–204. 22 indexed citations
16.
Pampillón, Clara, James Claffey, Katja Strohfeldt, & Matthias Tacke. (2007). Synthesis and cytotoxicity studies of new dimethylamino-functionalised and aryl-substituted titanocene anti-cancer agents. European Journal of Medicinal Chemistry. 43(1). 122–128. 26 indexed citations
17.
Pampillón, Clara, James Claffey, Megan Hogan, Katja Strohfeldt, & Matthias Tacke. (2007). Synthesis and cytotoxicity studies of new dimethylamino-functionalised and indolyl-substituted titanocene anti-cancer drugs. Transition Metal Chemistry. 32(4). 434–441. 43 indexed citations
18.
Hickey, Thomas E., et al.. (2007). Dimethylamino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studies. Investigational New Drugs. 25(5). 425–433. 11 indexed citations
19.
Pampillón, Clara, James Claffey, Megan Hogan, & Matthias Tacke. (2007). Morpholino‐Functionalized and Heteroaryl‐Substituted Titanocene Anti‐Cancer Drugs: Synthesis and Cytotoxicity Studies. Zeitschrift für anorganische und allgemeine Chemie. 633(10). 1695–1700. 8 indexed citations
20.
Hogan, Megan, James Claffey, Clara Pampillón, R. William G. Watson, & Matthias Tacke. (2007). Synthesis and Cytotoxicity Studies of New Dimethylamino-Functionalized and Azole-Substituted Titanocene Anticancer Drugs. Organometallics. 26(10). 2501–2506. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Surajit Chattopadhyay Breakdown of academic impact, for papers by R. W. Matthews Breakdown of academic impact, for papers by Dennis L. Nosco Breakdown of academic impact, for papers by R. Venkataramanan Breakdown of academic impact, for papers by Yvon Coulais Breakdown of academic impact, for papers by David G. Parsons Breakdown of academic impact, for papers by Noriyoshi Yamamoto Breakdown of academic impact, for papers by Stephen Wolstenhulme Breakdown of academic impact, for papers by Hidetoshi Inoue Breakdown of academic impact, for papers by Clark Smith
Rankless by CCL
2026